Does ER-betacx really have no clinical importance in tamoxifen-treated breast cancer patients?
Palmieri
Carlo
C
Gojis
Ondrej
O
Rudraraju
Bharath
B
Cleator
Susan
S
D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy*; D019008:Drug Resistance, Neoplasm; D047629:Estrogen Receptor beta / Q000032:analysis*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D011237:Predictive Value of Tests; D020033:Protein Isoforms; D012372:ROC Curve; D015203:Reproducibility of Results; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*; D013629:Tamoxifen / Q000627:therapeutic use*; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; D047629:Estrogen Receptor beta; D020033:Protein Isoforms; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen